glp-1 and kidney Real-World Evidence for Receptor Agonists Across the CKD Spectrum – AJKD Blog glp-1 and kidney disease glp-1

Co-infusion of GLP-1 and GCG has been shown to reduce glucagon-induced hyperglycemia, lower blood glucose levels, suppress food intake, and enhance energy expenditure in both diabetic obese mice and healthy human volunteers [78]

A retrospective medical database analysis of T2D patients (n = 39,275) treated with exenatide or other glucose-lowering therapies (n = 381,218) indicated that the GLP-1 agonist might reduce in 19% the incidence of MACCE and in 12% cardiovascular hospitalizations [71]

Red or pink urine May indicate blood in urine (hematuria) or food/medication pigments

(Lond.) 34 , 14271433 (2010)

Their effectiveness in the long run requires their combination with the following: Healthy eating habits Regular physical activity Ongoing medical supervision The weight loss from GLP-1 drugs must be slow and sustainable rather than quick and erratic

GLP-1/GIP + B12 is our advanced compounded medication, carefully designed to combine the benefits of GLP-1/GIP + B12 with additional supportive ingredients